abstract |
The present invention relates to compounds of formula (I) wherein R<SUP>1</SUP>, R<SUP>2</SUP> and R<SUP>3</SUP> are as defined hereinabove which are active at the GABA<SUB>B</SUB> receptor and which can be used for the preparation of medicaments useful in the control or prevention of CNS disorders. |